善治視角下的人類胚胎研究政策的制訂

Policy Formulation for Human Embryo Research from the Perspective of Good Governance

Abstract

LANGUAGE NOTE | Document text in Chinese; abstract also in English.

人類胚胎研究的“十四天規則”作為一條重要的倫理原則已實施四十餘年，被很多國家立法採納。近年來，隨著胚胎技術的飛速發展，科學家們對“十四天規則”提出了新的挑戰，也是對相關的倫理研究和公共政策的制訂提出的挑戰，即我們該怎樣看待人類胚胎研究的公共政策？Ana S litis等在〈新興人體胚胎研究技術、十四天規則和胚胎的特殊地位〉（馬修斯、洛伊、伊爾蒂斯2021）一文中鼓勵科學家從促進善治的角度來看待人類胚胎和胚狀體的研究政策，但並未深入探討其原因和意義，本文主要從善治的特徵出發通過對人類胚胎研究政策制訂中如何實現的探討而對該文的上述核心觀點進行回應。

In the article “Emerging Human Embryo Research Technologies, the 14-day Rule, and the Special Status of the Embryo,” one of the authors' core aims is to encourage scientists to look at human embryo research policy from the perspective of promoting good governance. Starting with the characteristics of good governance, this paper responds to Iltis et al. by discussing how to realize good governance in the formulation of human embryo research policy.